Editor: What To Know
- This strategic decision marks a pivotal moment for Beyeonics Vision as it reaffirms the commitment to advancing technological breakthroughs in the fields of Ophthalmology and prepares for its next phase of growth.
- , a pioneering MedTech company in the field of digital surgical platforms for imaging during ophthalmic procedures, announces the appointment of Burton Tripathi, PhD, as its new Chief Executive Officer.
- Together we are committed to building on the company’s groundbreaking innovation and advancing our mission to transform patient care in Ophthalmology”, Dr.
Dr A Burton Tripathi
Beyeonics Vision Ltd., a pioneering MedTech company in the field of digital surgical platforms for imaging during ophthalmic procedures, announces the appointment of Burton Tripathi, PhD, as its new Chief Executive Officer. This strategic decision marks a pivotal moment for Beyeonics Vision as it reaffirms the commitment to advancing technological breakthroughs in the fields of Ophthalmology and prepares for its next phase of growth.
Experience
Dr. Tripathi brings over two decades of Medical Device leadership experience, specializing in developing disruptive technologies, leading commercialization efforts, and facilitating M&A. Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.
New Role Responsibilities
In his new role as CEO of Beyeonics Vision, Dr. Tripathi will lead the company’s strategic direction, driving innovation and propelling the organization forward in its mission to revolutionize patient care in ophthalmology.
Yoram Shmuely, Chairman of the Beyeonics Vision Board
“We believe Mr. Tripathi’s leadership will continue to drive innovation and push forward Beyeonics Vision into the market. His appointment reflects our dedication to delivering cutting-edge solutions that enhance patient care. We also extend our gratitude to Mr. Ron Schnieder for his leadership in recent years, and we look forward to his continued contributions as a board member.”
Dr. Tripathi
“I am honored to be appointed as CEO of Beyeonics Vision. The company has an impressive portfolio of advanced technology and a talented team of employees. Together we are committed to building on the company’s groundbreaking innovation and advancing our mission to transform patient care in Ophthalmology”, Dr. Tripathi shared.
A leading figure in the transformation of surgical visualization from analog to digital, Dr. Tripathi, author of over 30 patents, has been instrumental in the adoption of digital imaging technology across all types of microsurgery. Dr. Tripathi has a Doctorate from the California Institute of Technology and a Bachelor’s from Cornell University both in Mechanical Engineering. He began his career at McKinsey & Company, followed by advancing leadership roles with Intuitive Surgical, Allergan, and Alcon.
